In four papers, #researchers and journalists take on aducanumab's controversial #FDAapproval
Their mission? Analyze what went wrong
NEW #Alzheimer’s Drug Controversy Continues ‣
top of page
bottom of page
In four papers, #researchers and journalists take on aducanumab's controversial #FDAapproval
Their mission? Analyze what went wrong
Opmerkingen